The company states: "Olink expects 2023 full year reported revenue to be in the range of $192 million to $200 million, representing growth of approximately 37% to 43% on a reported basis, and growth of approximately 38% to 44% on a constant currency basis. The Company expects revenues in 2023 will continue to progress along a seasonal pattern that is weighted toward the second half of the year, and fourth quarter specifically. In addition, Olink believes with continued growth and scale up, it will return to profitability in 2023, as measured by EBITDA excluding share-based compensation expenses."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on OLK:
- Olink initiated with an Outperform at Scotiabank
- Olink to participate in the 41st Annual JP Morgan Healthcare Conference
- Olink initiated with a Buy at Canaccord
- Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award
- Olink to hold an investor day